These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 39146663)

  • 1. A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey.
    Caballero C; Lundon DJ; Vasileva-Slaveva M; Montagna G; Bonci EA; Brandl A; Smith H; Kok JHH; Holmberg CJ; Sayyed R; Santrac N; Suppan I; Kaul P; Vassos N; Lorenzon L; Murphy M; Ceelen W; de Azambuja E; McIntosh SA; Rubio IT
    Eur J Surg Oncol; 2024 Oct; 50(10):108585. PubMed ID: 39146663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Can We Improve Education of Breast Surgeons Across Europe?
    Kolacinska A
    Chirurgia (Bucur); 2017; 112(4):365-366. PubMed ID: 28862111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges.
    Heil J; Kuerer HM; Pfob A; Rauch G; Sinn HP; Golatta M; Liefers GJ; Vrancken Peeters MJ
    Ann Oncol; 2020 Jan; 31(1):61-71. PubMed ID: 31912797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006).
    Gharzai LA; Szczygiel LA; Shumway DA; Bandos H; Julian TB; Mamounas EP; White J; De Los Santos JF; Basik M; Ganz PA; Jagsi R
    Breast Cancer Res Treat; 2021 Jun; 187(3):777-784. PubMed ID: 33740205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of axillary staging and management in clinically node positive breast cancer patients treated with neoadjuvant systemic therapy: Results of a survey amongst breast cancer specialists.
    Simons JM; Maaskant-Braat AJG; Luiten EJT; Leidenius MHK; van Nijnatten TJA; Boelens PG; Koppert LB; van der Pol CC; van de Velde CJH; Audisio RA; Smidt ML
    Eur J Surg Oncol; 2020 Jan; 46(1):53-58. PubMed ID: 31434617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance).
    Golshan M; Cirrincione CT; Sikov WM; Carey LA; Berry DA; Overmoyer B; Henry NL; Somlo G; Port E; Burstein HJ; Hudis C; Winer E; Ollila DW;
    Breast Cancer Res Treat; 2016 Nov; 160(2):297-304. PubMed ID: 27704226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional assessment in surgical oncology: An ESSO-EYSAC global survey.
    Lorenzon L; Brandl A; Guiral DC; Hoogwater F; Lundon D; Marano L; Montagna G; Polom K; Primavesi F; Schrage Y; Gonzalez-Moreno S; Kovacs T; D'Ugo D; Sandrucci S
    Eur J Surg Oncol; 2020 Nov; 46(11):2074-2082. PubMed ID: 32938568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omission of Breast Surgery in Exceptional Responders.
    Tasoulis MK; Lee HB; Kuerer HM
    Clin Breast Cancer; 2024 Jun; 24(4):310-318. PubMed ID: 38365541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons' Referrals.
    Mamounas E; Poulos C; Goertz HP; González JM; Pugh A; Antao V
    Ann Surg Oncol; 2016 Oct; 23(11):3510-3517. PubMed ID: 27283292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Treatment After Neoadjuvant Systemic Therapy in Young Women With Breast Cancer: Results From a Prospective Cohort Study.
    Kim HJ; Dominici L; Rosenberg SM; Zheng Y; Pak LM; Poorvu PD; Ruddy KJ; Tamimi R; Schapira L; Come SE; Peppercorn J; Borges VF; Warner E; Vardeh H; Collins LC; Gaither R; King TA; Partridge AH
    Ann Surg; 2022 Jul; 276(1):173-179. PubMed ID: 33378304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of neoadjuvant systemic therapy on breast conservation rates in patients with HER2-positive breast cancer: Surgical results from a phase II randomized controlled trial.
    Yamaguchi T; Hozumi Y; Sagara Y; Takahashi M; Yoneyama K; Fujisawa T; Osumi S; Akabane H; Nishimura R; Mieno MN; Mukai H
    Surg Oncol; 2021 Mar; 36():51-55. PubMed ID: 33310293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision making.
    Whitehead I; Irwin GW; Bannon F; Coles CE; Copson E; Cutress RI; Dave RV; Gardiner MD; Grayson M; Holcombe C; Irshad S; O'Brien C; O'Connell RL; Palmieri C; Shaaban AM; Sharma N; Singh JK; Potter S; McIntosh SA;
    BMC Cancer; 2021 Jan; 21(1):90. PubMed ID: 33482770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study.
    Simons JM; Koppert LB; Luiten EJT; van der Pol CC; Samiei S; de Wilt JHW; Siesling S; Smidt ML
    Breast Cancer Res Treat; 2020 Apr; 180(3):725-733. PubMed ID: 32180074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients With Pathologic Complete Response (ypT0 and ypN0) After Neoadjuvant Systemic Treatment for Omission of Breast and Axillary Surgery.
    Pfob A; Sidey-Gibbons C; Rauch G; Thomas B; Schaefgen B; Kuemmel S; Reimer T; Hahn M; Thill M; Blohmer JU; Hackmann J; Malter W; Bekes I; Friedrichs K; Wojcinski S; Joos S; Paepke S; Degenhardt T; Rom J; Rody A; van Mackelenbergh M; Banys-Paluchowski M; Große R; Reinisch M; Karsten M; Golatta M; Heil J
    J Clin Oncol; 2022 Jun; 40(17):1903-1915. PubMed ID: 35108029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentre prospective observational study evaluating recommendations for mastectomy by multidisciplinary teams.
    Mastectomy Decisions Audit (MasDA) Collaborative, on behalf of the West Midlands Research Collaborative
    Br J Surg; 2020 Feb; 107(3):227-237. PubMed ID: 31691270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality assessment of neoadjuvant therapy use in breast conservation: barriers to implementation.
    James T; McCahill L; Ratliff J; Ashikaga T; Single R; Sheehey-Jones J; Messier N; Stanley M; Krag D; Harlow S
    Breast J; 2009; 15(5):524-6. PubMed ID: 19624412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Policy statement on multidisciplinary cancer care.
    ; Borras JM; Albreht T; Audisio R; Briers E; Casali P; Esperou H; Grube B; Hamoir M; Henning G; Kelly J; Knox S; Nabal M; Pierotti M; Lombardo C; van Harten W; Poston G; Prades J; Sant M; Travado L; Valentini V; van de Velde C; van den Bogaert S; van den Bulcke M; van Hoof E; van den Neucker I; Wilson R
    Eur J Cancer; 2014 Feb; 50(3):475-80. PubMed ID: 24321260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omission of breast surgery in selected breast cancer patients with excellent response to neoadjuvant systemic therapy.
    Tasoulis MK; Muktar S; Smith I; Roche N; MacNeill F
    Eur J Surg Oncol; 2024 Jun; 50(6):108277. PubMed ID: 38522333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Therapy Advances for HER2-Positive and Triple Negative Breast Cancer: What the Surgeon Needs to Know.
    Downs-Canner S; Weiss A
    Clin Breast Cancer; 2024 Jun; 24(4):328-336. PubMed ID: 38616443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy.
    Kuerer HM; Rauch GM; Krishnamurthy S; Adrada BE; Caudle AS; DeSnyder SM; Black DM; Santiago L; Hobbs BP; Lucci A; Gilcrease M; Hwang RF; Candelaria RP; Chavez-MacGregor M; Smith BD; Arribas E; Moseley T; Teshome M; Miggins MV; Valero V; Hunt KK; Yang WT
    Ann Surg; 2018 May; 267(5):946-951. PubMed ID: 28549010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.